Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Essentra FY adjusted operating profits seen in line with previous guidance

(Sharecast News) - Plastic and fibre products supplier Essentra said on Wednesday that it expects full-year adjusted operating profits to be in line with previous guidance following a "resilient Q4 performance".

Essentra said it had seen "a sequential improvement" in performance during the fourth quarter when compared to the previous quarter, with group revenue down 3.6% year-on-year on a like-for-like basis, an improvement on the 7.1% decline reported in Q3, as comparatives continued to ease after a strong first-half performance in the prior year.

The FTSE 250-listed group said its European, Middle East, and Africa operations saw an improvement in new order momentum in Q4, while its American unit saw trading stability quarter-on-quarter, and remains focused on the improvement in destocking trends within distributor end-market channels. Essentra's Asia-Pacific business continued to demonstrate "a gradual recovery".

Essentra added that through a combination of "disciplined and proactive initiatives" taken through 2023, group adjusted operating margins remained strong. Central corporate costs, which were re-sized in the first half of 2023, continue to be "well managed", and remain in line with previous guidance of approximately £13.0m.

"With a robust and differentiated business model, underpinned by its breadth of customers, end market categories and geographical diversification, Essentra is well positioned, and continues to demonstrate through-cycle financial resilience. The group's balance sheet and cash generation remain strong, providing optionality for investment in organic growth initiatives and earnings enhancing M&A," said Essentra.

As of 0935 GMT, Essentra shares were down 3.16% at 153.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Supermarket Income REIT buys portfolio of Carrefour supermarkets for €75.3m
(Sharecast News) - Supermarket Income REIT said on Monday that it has bought a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction for €75.3m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.